Novo Nordisk

Novo Nordisk is a leading global​healthcare company, founded in 1923​ and headquartered in Denmark, whose purpose is to drive change to defeat serious chronic diseases, built upon the company’s heritage in diabetes.  Novo Nordisk does so by pioneering scientific breakthroughs, expanding access to Novo Nordisk medicines, and working to prevent and ultimately​cure disease.  On May 1st, 2024, the Athlone Site officially became a part of Novo Nordisk, to provide facilities for the development, production, quality control and release of oral Novo Nordisk products.